These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 4884768)

  • 21. A new look at biochemical tests of liver function.
    Miloszewski K; Walker BE; Hamilton M; Losowsky MS
    Rev Eur Etud Clin Biol; 1970 Oct; 15(8):878-81. PubMed ID: 5496773
    [No Abstract]   [Full Text] [Related]  

  • 22. [Study on the purification of bromosulphathalein. Disturbances in hepatobiliary diseases and possibilities of isolated BSP pathology].
    Ramboer C; De Groote J
    Tijdschr Gastroenterol; 1968; 11(1):36-51. PubMed ID: 5667545
    [No Abstract]   [Full Text] [Related]  

  • 23. [Laparoscopy in diseases of the liver, biliary tract, and pancreas].
    Khamdanov KhKh; Sabirov BU; Salokhiddinov BM
    Khirurgiia (Mosk); 1983 Aug; (8):143-6. PubMed ID: 6226821
    [No Abstract]   [Full Text] [Related]  

  • 24. [Chromocholoscopy with sulfobromophthalein in the preoperative study of diseases of the biliary tract].
    Taschieri AM; Pucci C; Scortecci V; Trivellini G
    Arch Ital Chir; 1967; 93(1):40-72. PubMed ID: 5621859
    [No Abstract]   [Full Text] [Related]  

  • 25. The diagnosis of jaundice.
    Gastroenterology; 1984 Feb; 86(2):380-3. PubMed ID: 6690364
    [No Abstract]   [Full Text] [Related]  

  • 26. [Action of glucagon on bile flow and hepatic "storage" and maximum biliary excretion of BSF in the dog].
    Sardi GF; Curti B; Brocchi G; Ramello A; Chiandussi L
    Boll Soc Ital Biol Sper; 1969 Feb; 45(3):215-7. PubMed ID: 5346802
    [No Abstract]   [Full Text] [Related]  

  • 27. [Liver clearance of bromosulphalein (BSF) in cirrhosis].
    Rodés J; Bordas JM; Bruguera M; Terés J
    Rev Clin Esp; 1968 Nov; 111(3):303-14. PubMed ID: 5736056
    [No Abstract]   [Full Text] [Related]  

  • 28. [The pathological breakdown of the two-color dye tests in participation of the liver in non-liver disease occurrences].
    Bargon G; Hochmiller C
    Acta Hepatosplenol; 1966; 13(4):201-7. PubMed ID: 5987791
    [No Abstract]   [Full Text] [Related]  

  • 29. [The free bilirubin tolerance test as a liver function test and its comparison with the BSF tolerance test].
    Gentilini P; Surrenti C; Candidi Tommasi A; Camilloni R
    Sperimentale; 1969; 119(4):281-97. PubMed ID: 5402934
    [No Abstract]   [Full Text] [Related]  

  • 30. Sulfobromophtaalein sodium excretion and hepatic storage in Corriedale and Southdown sheep with inherited hepatic dysfunction.
    Gronwall R
    Am J Vet Res; 1970 Dec; 31(12):2131-3. PubMed ID: 5505142
    [No Abstract]   [Full Text] [Related]  

  • 31. ABC of diseases of liver, pancreas, and biliary system. Investigation of liver and biliary disease.
    Beckingham IJ; Ryder SD
    BMJ; 2001 Jan; 322(7277):33-6. PubMed ID: 11141153
    [No Abstract]   [Full Text] [Related]  

  • 32. Measurements of hepatic storage and of maximal biliary transport of sulfobromophthalein sodium in man. Comparison of values obtained with two and three infusion rates.
    Adams RH; Gordon J; Combes B
    Gastroenterology; 1966 Sep; 51(3):373-6. PubMed ID: 5945817
    [No Abstract]   [Full Text] [Related]  

  • 33. [Clinical manifestations of increased pressure of the biliary tract].
    Keclik M
    Dtsch Z Verdau Stoffwechselkr; 1965 Oct; 25(4):165-8. PubMed ID: 5888874
    [No Abstract]   [Full Text] [Related]  

  • 34. [Hepatic function tests].
    Barroso AO
    Rev Bras Med; 1966 Mar; 23(3):168-75. PubMed ID: 5940583
    [No Abstract]   [Full Text] [Related]  

  • 35. [Clinico-statistical evaluation of the simultaneous clearance of sulfobromophthalein and galactose in chronic liver diseases].
    Rossi L; Innocenti P; Milani A; Bombardieri G
    Quad Sclavo Diagn; 1983 Jun; 19(2):271-84. PubMed ID: 6676775
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Dynamics of BSF during partial obstruction of the biliary tract in dogs. 3. Increase of plasmatic retention and lymphatic drainage of BSF].
    Sardi GF; Curti B; Brocchi G; Puggioni G; Chiandussi L
    Boll Soc Ital Biol Sper; 1969 Feb; 45(3):209-11. PubMed ID: 5346800
    [No Abstract]   [Full Text] [Related]  

  • 37. [Clinical study on the hepatic eliminatory competition of bilirubin and bromosulphalein].
    Alves J; Santolaria F; Cabarcos A; Huguet R; Bruguera JA; Liso P
    Rev Esp Enferm Apar Dig; 1974 Dec; 44(7):687-96. PubMed ID: 4445552
    [No Abstract]   [Full Text] [Related]  

  • 38. [Jaundice].
    Iakhontova OI; Rutgaĭzer IaM; Valenkevich LN
    Klin Med (Mosk); 1998; 76(10):59-64. PubMed ID: 9865023
    [No Abstract]   [Full Text] [Related]  

  • 39. [Sulfobromophthalein kinetics in normal subjects and patients with alcoholic cirrhosis (author's transl)].
    Biagi P; Bocchini S; Vernarecci G
    Quad Sclavo Diagn; 1979 Sep; 15(3):1007-16. PubMed ID: 554996
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Hepatic clearance of sulfobromophthalein administered in small doses in subjects with hepatobiliary diseases].
    Cravario A; Molino G; Giangrandi E
    Minerva Gastroenterol; 1966; 12(4):135-41. PubMed ID: 5993623
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.